ASHOK KUMAR to Head and Neck Neoplasms
This is a "connection" page, showing publications ASHOK KUMAR has written about Head and Neck Neoplasms.
Connection Strength
0.058
-
Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer. Invest New Drugs. 2008 Feb; 26(1):81-7.
Score: 0.044
-
Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys. 2011 Apr 01; 79(5):1487-95.
Score: 0.014